Geographic · Long-Lived Assets
Other European countries — Long-Lived Assets
West Pharmaceutical Services Other European countries — Long-Lived Assets increased by 10.8% to $108.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $98.10M to $108.70M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025
Rolls up toPP&E (Net)
How to read this metric
An increase suggests capital investment and expansion of regional operational capacity, whereas a decrease may indicate asset divestiture, impairment, or a shift in regional strategy.
Detailed definition
This metric measures the total value of non-current, tangible, and intangible assets held by the company within the spec...
Peer comparison
Global manufacturing firms report long-lived assets by geography to allow investors to evaluate regional operational risk and capital intensity.
Metric ID:
wst_segment_other_european_countries_long_lived_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $65.10M | $81.80M | $99.20M | $98.10M | $108.70M |
| QoQ Change | — | +25.7% | +21.3% | -1.1% | +10.8% |
| YoY Change | — | +25.7% | +21.3% | -1.1% | +10.8% |
Range$65.10M – $108.70M
CAGR+67.0%
Avg YoY Growth+14.2%
Median YoY Growth+16.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other european countries — long-lived assets?
- West Pharmaceutical Services (WST) reported other european countries — long-lived assets of $108.70M in Q4 2025.
- How has West Pharmaceutical Services's other european countries — long-lived assets changed year-over-year?
- West Pharmaceutical Services's other european countries — long-lived assets increased by 10.8% year-over-year, from $98.10M to $108.70M.
- What does other european countries — long-lived assets mean?
- The total value of long-term assets located in secondary European countries.